PATENT CLAIM ANALYSIS

Application Number: 16142667
Application Type: Utility
Filing Date: 2018-09
Publication Date: 2019-03
Patent Classification: ["514", "235800"]

Abstract:
The present disclosure teaches methods for treating and preventing a variety of neurodegenerative conditions and symptoms associated therewith, including Alzheimer's disease (AD) and idiopathic Parkinson's disease (iPD), by utilizing adrenoceptor antagonists. Adrenoceptor antagonists that can be used include β-blockers, such as acebutolol, betaxolol, bisopropolol, bopindolol, carvedilol, metoprolol, oxprenolol, propranolol, and timolol. The present disclosure also teaches methods for diagnosing and monitoring the progression of iPD.

Claim (Index 2):
The method of  claim 1 , wherein the neurodegenerative condition is selected from the group consisting of idiopathic Parkinson's disease (iPD), Dementia with Lewy Bodies (DLB), Multiple System Atrophy (MSA), Pure Autonomic Failure (PAF), Alzheimer's disease (AD), Progressive Supranuclear Palsy (PSP), Cortico-Basal Degeneration (CBD), and Huntington's Disease (HD).

Metadata:
- Claim Count in Document: 53.0
- Percentile: 97.0
- Lexical Diversity: 1.51786
- Patent Class: 514.0
- Transitional Phrase Type: closed
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['14900315', '15451144', '12997767', '15253737', '14098890']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.776560525805981
- 35 USC 102 Novelty (BERT): 0.5792388895789677
- Combined Prediction Score: 0.7568283621832798
- Mean Citation Score: 236.613384
- Max Citation Score: 478.96136
- Similarity Product: 423.6637746905232

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test